EA201401202A1 - ВАКЦИНАЦИЯ РЕСПИРАТОРНЫМ КОРОНАВИРУСОМ СОБАК ДЛЯ ЗАЩИТЫ ОТ ИНФЕКЦИЙ B.Bronchiseptica - Google Patents

ВАКЦИНАЦИЯ РЕСПИРАТОРНЫМ КОРОНАВИРУСОМ СОБАК ДЛЯ ЗАЩИТЫ ОТ ИНФЕКЦИЙ B.Bronchiseptica

Info

Publication number
EA201401202A1
EA201401202A1 EA201401202A EA201401202A EA201401202A1 EA 201401202 A1 EA201401202 A1 EA 201401202A1 EA 201401202 A EA201401202 A EA 201401202A EA 201401202 A EA201401202 A EA 201401202A EA 201401202 A1 EA201401202 A1 EA 201401202A1
Authority
EA
Eurasian Patent Office
Prior art keywords
dogs
vaccination
protection against
corona virus
respiratory corona
Prior art date
Application number
EA201401202A
Other languages
English (en)
Other versions
EA032284B1 (ru
Inventor
Шелли Линн Шилдз
Омар Иосиф Абдельмагид
Original Assignee
Зоэтис Ллс
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Зоэтис Ллс filed Critical Зоэтис Ллс
Publication of EA201401202A1 publication Critical patent/EA201401202A1/ru
Publication of EA032284B1 publication Critical patent/EA032284B1/ru

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/215—Coronaviridae, e.g. avian infectious bronchitis virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/099—Bordetella
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/58—Medicinal preparations containing antigens or antibodies raising an immune response against a target which is not the antigen used for immunisation
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/20011—Coronaviridae
    • C12N2770/20032—Use of virus as therapeutic agent, other than vaccine, e.g. as cytolytic agent
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/20011—Coronaviridae
    • C12N2770/20034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Virology (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Epidemiology (AREA)
  • Communicable Diseases (AREA)
  • Pulmonology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

В данной заявке представлены композиции и комбинации, включающие респираторные коронавирусы собак (CRCoV), и способы, эффективные для лечения или профилактики респираторных инфекций у животных, связанных с вторичными патогенами, такими как Bordetella bronchiseptica.
EA201401202A 2012-05-31 2013-05-24 Вакцинация респираторным коронавирусом собак для защиты от инфекций в. bronchiseptica EA032284B1 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201261653558P 2012-05-31 2012-05-31
PCT/US2013/042590 WO2013181086A1 (en) 2012-05-31 2013-05-24 Vaccination with canine respiratory coronavirus for protection against b. bronchiseptica infections

Publications (2)

Publication Number Publication Date
EA201401202A1 true EA201401202A1 (ru) 2015-08-31
EA032284B1 EA032284B1 (ru) 2019-05-31

Family

ID=48626613

Family Applications (1)

Application Number Title Priority Date Filing Date
EA201401202A EA032284B1 (ru) 2012-05-31 2013-05-24 Вакцинация респираторным коронавирусом собак для защиты от инфекций в. bronchiseptica

Country Status (12)

Country Link
US (1) US10632189B2 (ru)
EP (1) EP2854847B1 (ru)
JP (1) JP6313752B2 (ru)
CN (1) CN104411330B (ru)
AU (1) AU2013267716B2 (ru)
BR (1) BR112014029725B1 (ru)
CA (1) CA2874966C (ru)
EA (1) EA032284B1 (ru)
ES (1) ES2748205T3 (ru)
MX (1) MX363510B (ru)
NZ (1) NZ701930A (ru)
WO (1) WO2013181086A1 (ru)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN114514238A (zh) * 2019-07-12 2022-05-17 研究发展基金会 埃立克体疫苗和免疫原性组合物
US20230012140A1 (en) * 2019-12-18 2023-01-12 Intervet Inc. Oral respiratory vaccine
RU2733831C1 (ru) * 2020-07-08 2020-10-07 Федеральное государственное учреждение науки "Государственный научный центр вирусологии и биотехнологии "Вектор" Федеральной службы по надзору в сфере защиты прав потребителей и благополучия человека (ФБУН ГНЦ ВБ "Вектор" Роспотребнадзора) Искусственный ген, кодирующий бицистронную структуру, образованную последовательностями рецептор-связующего домена гликопротеина S коронавируса SARS-CoV-2, P2A-пептида и гликопротеина G VSV, рекомбинантная плазмида pStem-rVSV-Stbl_RBD_SC2, обеспечивающая экспрессию искусственного гена и рекомбинантный штамм вируса везикулярного стоматита rVSV-Stbl_RBD_SC2, используемого для создания вакцины против коронавируса SARS-CoV-2
RU2768749C1 (ru) * 2021-06-07 2022-03-24 Федеральное государственное бюджетное учреждение "Федеральный центр охраны здоровья животных" (ФГБУ "ВНИИЗЖ") Средство специфической профилактики covid-19 для плотоядных животных

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2571618A1 (fr) 1984-10-12 1986-04-18 Virbac Ctre Rech Biolog Nouveau vaccin contre la tracheobronchite infectieuse canine et son procede de preparation
US5703055A (en) 1989-03-21 1997-12-30 Wisconsin Alumni Research Foundation Generation of antibodies through lipid mediated DNA delivery
AU2001249300B2 (en) * 2000-04-03 2006-02-16 The University Of Pittsburgh-Of The Commonwealth System Of Higher Education Cold-adapted equine influenza viruses
GB0217434D0 (en) 2002-07-27 2002-09-04 Royal Vetinary College Biological material
DE10237102A1 (de) * 2002-08-13 2004-02-26 Bayerische Motoren Werke Ag Integralbremsanlage für Motorräder
MXPA05008051A (es) 2003-01-29 2005-09-21 Pfizer Prod Inc Vacunas caninas contra bordetella bronchiseptica.
GB0315323D0 (en) 2003-07-01 2003-08-06 Royal Veterinary College Vaccine composition
US7959929B2 (en) 2005-04-21 2011-06-14 University Of Florida Research Foundation, Inc. Materials and methods for respiratory disease control in canines
CA2674026C (en) * 2006-12-27 2018-08-21 Pfizer Products Inc. Methods of vaccine administration
WO2011112593A1 (en) * 2010-03-10 2011-09-15 Intervet International B.V. Method for protecting against disease caused by secondary pathogens
PL2670432T3 (pl) * 2011-02-04 2021-10-11 Zoetis Services Llc Kompozycje immunogenne Bordetella bronchiseptica
CA2826058C (en) * 2011-02-04 2017-06-06 Zoetis Llc Compositions for canine respiratory disease complex
CN102714345B (zh) * 2012-03-09 2014-11-05 华为技术有限公司 天线系统、基站和通信系统

Also Published As

Publication number Publication date
NZ701930A (en) 2016-10-28
JP6313752B2 (ja) 2018-04-18
EP2854847B1 (en) 2019-08-07
US10632189B2 (en) 2020-04-28
AU2013267716A1 (en) 2014-11-27
BR112014029725B1 (pt) 2023-09-26
AU2013267716B2 (en) 2018-03-08
HK1206265A1 (en) 2016-01-08
ES2748205T3 (es) 2020-03-13
MX363510B (es) 2019-03-26
BR112014029725A8 (pt) 2018-04-03
EA032284B1 (ru) 2019-05-31
US20150157706A1 (en) 2015-06-11
CN104411330B (zh) 2017-02-22
WO2013181086A1 (en) 2013-12-05
CA2874966A1 (en) 2013-12-05
CA2874966C (en) 2020-06-09
CN104411330A (zh) 2015-03-11
BR112014029725A2 (pt) 2017-06-27
JP2015518047A (ja) 2015-06-25
MX2014014652A (es) 2015-02-24
EP2854847A1 (en) 2015-04-08

Similar Documents

Publication Publication Date Title
EA201692303A1 (ru) Новая противоинфекционная стратегия против коинфекций, вызванных вирусом гриппа и s.aureus
EA201690979A1 (ru) Производные азепана и способы лечения инфекций гепатита в
MX2023002533A (es) Composiciones y metodos para proteger contra patogenos e irritantes transportados por el aire.
EA201690406A1 (ru) Селективные ингибиторы grp94 и способы их применения
EA201691440A1 (ru) Производные азепана и способы лечения инфекций гепатита в
CY1122305T1 (el) Ενωσεις υδροξαζολης υδροξαμικου οξεος ως αναστολεις lpxc
EA201690556A1 (ru) Способы и фармацевтические композиции для лечения вызванных вирусом гепатита в инфекций
CR20160337A (es) Nuevas heteroarildihidropirimidinas 6-fusionadas para el tratamiento y la profilaxis de la infección por virus de la hepatitis b
EA201790273A1 (ru) Флагеллиновые композиции и их применение
MX373444B (es) Compuestos organicos de monobactam para el tratamiento de infecciones bacterianas.
EA201491889A1 (ru) Соединения и способы для противовирусной терапии
EA201391536A1 (ru) Противомикробные соединения и способы их получения и применения
EA201591812A1 (ru) Противомикробные полиамидные композиции и лечение мастита
CY1124093T1 (el) Ανοσογονικες συνθεσεις bordetella bronchiseptica
EA201692358A1 (ru) Производные изоиндолина для применения в лечении вирусной инфекции
CR20140367A (es) Inhibidores de iap
EA201491500A1 (ru) Способы лечения фиброза
PH12016502001A1 (en) Novel bacteriophage and composition comprising same
BR112014025339A8 (pt) método para tratamento ou prevenção ou redução de infecção do virus influenza e composição farmacêutica para o mesmo.
MX2015003564A (es) Composiciones y metodos de uso de un compuesto de control de inapetencia.
EA201401202A1 (ru) ВАКЦИНАЦИЯ РЕСПИРАТОРНЫМ КОРОНАВИРУСОМ СОБАК ДЛЯ ЗАЩИТЫ ОТ ИНФЕКЦИЙ B.Bronchiseptica
BR112015016033A2 (pt) composições e métodos para tratamento de infecções por bactérias
MX371126B (es) Vacuna para cerdos contra el sindrome reproductivo y respiratorio porcino y lawsonia intracellularis.
IN2013MU03216A (ru)
BR112013019850A8 (pt) Composições de vacina e seu uso no tratamento ou prevenção de doenças respiratórias infecciosas caninas

Legal Events

Date Code Title Description
MM4A Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s)

Designated state(s): AM AZ BY KZ KG TJ TM